BioForce Nanosciences Holdings, Inc.
OTC:BFNH
2.29 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0.018 | 0.016 | 0.005 | 0.008 | 0.006 | 0 | 0.027 | 0 | 1.125 | 0.415 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0.013 | 0.012 | 0.003 | 0.006 | 0.005 | 0 | 0 | 0 | 0.601 | 0.199 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0.004 | 0.005 | 0.001 | 0.002 | 0.001 | 0 | 0.027 | 0 | 0.524 | 0.216 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0.245 | 0.286 | 0.279 | 0.273 | 0.131 | 0 | 1 | 0 | 0.466 | 0.52 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.146 | 0.839 | 0 |
| General & Administrative Expenses
| 0.472 | 0.486 | 0.502 | 158.409 | 0.051 | 0.071 | 0.033 | 0.003 | 0.003 | 0.003 | 0.005 | 0.004 | 3.173 | 2.523 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.232 | 0 | 0 |
| SG&A
| 0.472 | 0.486 | 0.502 | 158.409 | 0.051 | 0.071 | 0.033 | 0.003 | 0.003 | 0.003 | 0.005 | 0.004 | 3.173 | 2.523 | 0.017 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0 | 0 |
| Operating Expenses
| 0.472 | 0.486 | 0.502 | 158.409 | 0.051 | 0.071 | 0.033 | 0.003 | 0.003 | 0.003 | 0.005 | 0.004 | 4.321 | 3.362 | 0.017 |
| Operating Income
| -0.472 | -0.486 | -0.502 | -158.409 | -0.047 | -0.067 | -0.031 | -0.003 | -0.003 | -0.003 | 0.022 | -0.004 | -3.797 | -3.146 | -0.017 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | -2.618 | -4.092 | -6.947 | -0.303 | -0.412 | 0 | 0.83 | 0 | -3.375 | -7.58 | 0 |
| Total Other Income Expenses Net
| -0 | -0 | 0 | 0 | 0 | -0.001 | -0 | -0 | 0 | 0 | 0 | 0 | -0.092 | -0.828 | 0 |
| Income Before Tax
| -0.472 | -0.486 | -0.502 | -158.409 | -0.047 | -0.068 | -0.031 | -0.003 | -0.003 | -0.003 | 0.022 | -0.004 | -3.854 | -3.974 | 0 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | -2.618 | -4.153 | -6.947 | -0.303 | -0.412 | 0 | 0.83 | 0 | -3.426 | -9.574 | 0 |
| Income Tax Expense
| -0.472 | -0 | -0 | -0.158 | -0 | 0.002 | -0.031 | -0.006 | -0.006 | 0 | 0 | 0 | 0.057 | 0 | 0.019 |
| Net Income
| -0.472 | -0.486 | -0.502 | -158.409 | -0.047 | -0.068 | -0.031 | -0.003 | -0.003 | -0.003 | 0.022 | -0.004 | -3.854 | -3.974 | -0.019 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | -2.618 | -4.153 | -6.947 | -0.303 | -0.412 | 0 | 0.83 | 0 | -3.426 | -9.574 | 0 |
| EPS
| -0.02 | -0.017 | -0.017 | -9.72 | -0.003 | -0.001 | -0 | -0 | -0 | -0 | 0.003 | -0.001 | -0.16 | -0.17 | -0.002 |
| EPS Diluted
| -0.016 | -0.017 | -0.017 | -9.72 | -0.003 | -0.001 | -0 | -0 | -0 | -0 | 0.003 | -0.001 | -0.16 | -0.17 | -0.002 |
| EBITDA
| -0.472 | -0.486 | -0.502 | -158.409 | -0.047 | -0.066 | -0.031 | -0.003 | -0.003 | -0.003 | 0.022 | -0.004 | -3.447 | -2.944 | -0.017 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | -2.618 | -4.031 | -6.947 | -0.303 | -0.412 | 0 | 0.83 | 0 | -3.064 | -7.092 | 0 |